| |
| |
|
| Insider
Information: |
Bate Kenneth |
| Relationship: |
Director |
| City: |
Cambridge, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
18,448 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,326,077 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,448 |
|
|
| Total
Value |
$1,326,077 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2015-06-10 |
11,875 |
2011-05-12 |
0 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Director |
2017-06-15 |
5,000 |
2017-06-15 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2021-06-11 |
0 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
Director |
2023-01-19 |
375 |
2023-01-19 |
0 |
Premium* |
|
|
Madrigal Pharmaceuticals Inc |
MDGL |
Director |
2024-04-02 |
1,198 |
2024-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2024-04-02 |
4 |
AS |
$243.28 |
$2,741,219 |
D/D |
(11,212) |
1,198 |
0 |
% |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2024-04-02 |
4 |
OE |
$105.08 |
$1,178,157 |
D/D |
11,212 |
12,410 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2024-04-01 |
4 |
AS |
$255.62 |
$5,473,779 |
D/D |
(21,277) |
1,198 |
0 |
% |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2024-04-01 |
4 |
OE |
$9.45 |
$1,233,187 |
D/D |
21,277 |
22,475 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2023-01-19 |
4 |
D |
$15.00 |
$5,625 |
D/D |
(375) |
375 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-08-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,054) |
0 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2022-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,994 |
17,054 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8,060 |
8,060 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Director |
– • – |
2017-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
11,875 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
10,775 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,400 |
8,675 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2012-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,400 |
5,275 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
1,875 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
